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Quantitative susceptibility mapping (QSM) is a recently developed magnetic resonance imaging (MRI) tech-
nique for quantifying the spatial distribution of magnetic susceptibility within biological tissues. It first uses the
frequency shift in the MRI signal to map the magnetic field profile within the tissue. The resulting field map is
then used to determine the spatial distribution of the underlying magnetic susceptibility by solving an inverse
problem. The solution is achieved by deconvolving the field map with a dipole field, under the assumption
that the magnetic field results from a superposition of the dipole fields generated by all voxels and that each
voxel has its own unique magnetic susceptibility. QSM provides an improved contrast-to-noise ratio for cer-
tain tissues and structures compared with its magnitude counterpart. More importantly, magnetic susceptibil-
ity directly reflects the molecular composition and cellular architecture of the tissue. Consequently, by quanti-
fying magnetic susceptibility, QSM is becoming a quantitative imaging approach for characterizing normal
and pathological tissue properties. This article reviews the mechanism that generates susceptibility contrast
within tissues and some associated applications.
INTRODUCTION
Quantitative susceptibility mapping (QSM) is a noninvasive
magnetic resonance imaging (MRI) technique that measures
the spatial distribution of magnetic susceptibility within an
object (1-15). In most common practices, QSM computes the
magnetic susceptibility from the phase images of gradient-
recalled echoes (GREs) with the assumption that the phase
shift results primarily from susceptibility-induced field inho-
mogeneity. This tomographic capability is unique—no other
imaging techniques provide such a 3D mapping of suscepti-
bility in the interior of an object with the measurement
equipment positioned outside of the object. In imaging bio-
logical tissues and specimens, QSM has revealed a diverse
range of tissue contrast in the brain and the body, reflecting
the variations of tissue magnetic susceptibility (6, 8, 10,
16-24). As more tissues are being studied, the mechanisms of
these contrasts are increasingly becoming more complex,
which has simultaneously also allowed more potential appli-
cations in both research and clinical radiology. This article
aims to review the basic mechanisms of the contrast gener-
ated by QSM and their associated applications.
HOW IS QSM GENERATED?
The field perturbations caused by inhomogeneous susceptibility
within a volume of interest (VOI) may be measured from MRI
phase data. GRE phase images can provide better contrast be-
tween gray and white matter in the brain than the corresponding
magnitude image (25-27). However, the phase measured in GRE
acquisitions is highly dependent on imaging parameters; more-
over, phase values are nonlocal; ie, the phase value measured in
a voxel depends not only on local tissue properties but also on
the surrounding magnetic susceptibility distribution. If the sus-
ceptibility-induced magnetization is treated as a magnetic di-
pole, then the field perturbation caused by a known distribution
of isotropic susceptibility can be obtained by convolving the
susceptibility distribution with a unit dipole kernel. This calcu-
lation may be performed simply and efficiently as a pointwise
multiplication in k-space (2, 3), such that
Bzk B013  kz2k2k (1)
where k is the k-space vector and kz its z-component; B0 is the
applied magnetic field, taken to be in the z-direction; Bz (k) is
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the Fourier transform of the z-component of the magnetic field
perturbation; and  (k) is the Fourier transform of the magnetic
susceptibility distribution. QSM is achieved by inverting this
equation (Figure 1). Although this inversion resolves the non-
local property of phase, QSM faces several challenges both in the
measurement of Bz and the ill-posed nature of the inversion
itself.
By scaling the measured phase by the gyromagnetic ratio
and echo time (TE) to generate a field map, Bz may be calcu-
lated from the GRE signal phase. However, it must be first
ensured that the phase is indeed caused by susceptibility and not
by other effects such as chemical shift, receiver-coil (B1 field)
and flow-induced phases. For example, it is important to sepa-
rate the phases induced by chemical shift when imaging regions
of the body that have high fat content. Once the susceptibility-
induced phase is isolated, the data must then be processed to
remove phase wraps and background fields generated by
sources outside of the VOI (Figure 1). Phase unwrapping can be
easily performed using path-based (28) or Laplacian-based (8,
29) unwrapping algorithms. Background fields can be removed
using a number of algorithms, including projection onto dipole
fields (7, 30, 31), SHARP processing and its variants (10, 11), and
the HARPERELLA algorithm (13). High-pass spatial filtering can
be used to simultaneously unwrap and filter the data; however,
this will also remove fields that are necessary for accurate QSM
inversion. The filtered phase is then divided by the TE, yielding
a map of frequency variation with respect to the reference
frequency of the scanner. The local field perturbation is then
given by Bz  /	, where  is the local frequency pertur-
bation and 	 the gyromagnetic ratio.
Recovering a susceptibility map from a local tissue field
map is more complex. The field map must be deconvolved with
the unit dipole kernel corresponding to a pointwise division in
k-space. This deconvolution is ill-posed because of zeros in the
k-space dipole kernel on 2 conical surfaces at approximately
54.7° with respect to the direction of the main magnetic field.
The inverse kernel is undefined at those surfaces, and noise is
greatly amplified in regions where the kernel is very small and
the inverse kernel is very large, making a simple inversion of the
forward calculation impossible. In general, QSM is achieved by
conditioning of the ill-posed inverse calculation to measure the
susceptibility distribution while excluding or minimizing noise
and artifacts.
Susceptibility maps may be calculated from a single GRE
acquisition using threshold-based masking or by modifying the
dipole kernel to remove or replace regions where the dipole
kernel is small and the inverse kernel is very large or undefined
(5, 7, 32). These algorithms are efficient and easy to implement;
however, they contain severe streaking artifacts as a result of the
information lost through the masking process, and a compro-
mise must be made between noise amplification and the reduc-
tion of streaking artifacts. Streaking in the focal areas of objects
with large susceptibilities such as blood vessels may be reduced
by estimating the missing data using iterative (33) or com-
pressed sensing (11) algorithms.
In addition to the conditioning of the direct inverse calcu-
lation, iterative fitting algorithms have been proposed for cre-
ating susceptibility maps by estimating the susceptibility distri-
bution as a solution to a minimization problem. In addition to
estimating the missing k-space data, various regularization-
based optimization algorithms have been proposed using L1-
norm (least absolute error) (9, 12, 20, 34) or L2-norm (least
squares error) (31, 35) regularization to find a solution. Weight-
ing based on spatial priors from the GRE magnitude (9, 36) or
phase (20) may be included in the calculation to reduce streak-
ing artifacts by enforcing smoothness in the solution in regions
where the susceptibility distribution is assumed to be flat. Al-
though these algorithms can generate good-quality susceptibil-
ity maps with minimal streaking artifacts, care must be taken on
the assumptions made when selecting spatial priors to avoid
reducing image contrast resulting from overregularization (9,
35, 36).
The entirety of k-space may be sampled using the calcula-
tion of susceptibility through a multiple-orientation sampling
(COSMOS) algorithm (4). COSMOS combines data from images
acquired with the region of interest oriented at multiple (
3)
angles with respect to B0. In the frame of reference of the region
of interest, the dipole kernel and its ill-defined surfaces are
rotated at each orientation. Appropriate selection of object ori-
entation allows the entirety of k-space to be sampled, with the
exception of the origin of coordinates, and a direct inversion to
be performed. The advantage of this algorithm is that the com-
plete sampling of k-space in the inversion process allows the
recovery of the susceptibility map free of streaking artifacts.
Figure 1. Flow chart of QSM. Magnitude and
phase images are acquired with a GRE sequence.
The magnitude image is used to create a mask of
the brain that provides the volume of interest. The
phase image is first unwrapped, and then a back-
ground phase filtering in the masked region fol-
lows. Finally, the susceptibility map is obtained by
solving an inverse problem.
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However, COSMOS is often impractical, particularly for in vivo
studies, because of the additional time and potential physical
difficulty in acquiring images over a range of orientations.
Although QSM has been shown by experiments to find the
magnetic susceptibility distribution underlying the measured
MRI signal phase with good accuracy (4, 7), its accuracy is
limited by its inherent assumption that the susceptibility is
isotropic in nature. In reality, some molecules such as lipids in
myelin, collagen, and -helix polypeptide (eg, in myocardial
filaments) have been shown to have an anisotropic susceptibility
characterized by a susceptibility tensor, creating an orientation-
dependent magnetization when exposed to a magnetic field.
Where such molecules form ordered structures such as myelin
sheath in the brain, this can result in a measured susceptibility in
QSM that varies with orientation with respect to B0. The suscep-
tibility anisotropy within a voxel can be measured with suscep-
tibility tensor imaging (STI) (6). STI has been used to create
high-resolution fiber tracks in the mouse brain (37) and kidney
(38).
WHERE DOES MAGNETIC SUSCEPTIBILITY COME
FROM?
The general physical models of how materials become magne-
tized have become very complex given the range of natural and
manmade materials that exist with diverse magnetic properties
(39). Although the theory of electromagnetics is described by
Maxell’s equations, modeling magnetism of different materials
remains a very active field of research. Much of the complexity
results from the need to fully understand the collective behavior
of a vast number of electrons in many different types of mate-
rials, as magnetism is believed to be predominantly contributed
by the magnetic moments of electrons, with contribution from
nuclear moments being negligibly small. A simple model of
magnetism starting from noninteracting moments, although
incomplete (eg, it does not explain the sharp transition of Curie
temperature, ferromagnetism, or superconductivity), has been
useful for understanding the origins of paramagnetic and dia-
magnetic susceptibility.
In an atom or molecule, electrons are distributed into dif-
ferent energy levels with quantized spin and orbital angular
momentum, which gives rise to a set of quantized magnetic
moments (39)
sgsB
S

 B (2)
LgLB
L

(3)
where s and L are the magnetic moment of an electron
resulting from its spin and angular momentum respectively; g is
the Landé g-factor; s and L are the spin and orbital angular
momentum quantum number, respectively;  is the reduced
Planck constant; and B is the Bohr magneton (Figure 2A). The
probability of finding an electron with a given set of quantum
numbers follows the Boltzmann’s distribution, which in turn
gives an effective magnetic moment eff. As a rule of thumb, the
more unpaired electrons there are the larger the effective mag-
netic moment is, because paired electrons tend to cancel each
other. For linear materials, magnetization (M) is proportional to
the magnetic field (H), ie, M  H or, in a differential form,
  M/H. Therefore,   eff
2 T, with the temperature coef-
ficient being the Curie temperature C (Figure 2A).
In addition to the aforementioned paramagnetism, the pres-
ence of an external field also causes the electrons to precess
about the applied field, generating a secondary field that op-
poses the applied field thus giving rise to diamagnetism. Ac-
cording to the Langevin theory (a classic model of nonquantum
mechanics), the magnetic moment of this induced current is (39)

Ne20H
4me
2 (4)
where N is the number of electrons per unit volume; e is the
electron charge; me is the electron mass; 0 is vacuum perme-
ability; and 2 is the mean square distance of the electrons
perpendicular to the H direction (Figure 2B). Therefore, the
diamagnetic susceptibility is  Ne204me2, which imme-
diately indicates that (1) this susceptibility is negative and (2)
nonspherical molecules would have anisotropic magnetic sus-
ceptibility because the cross-section area is orientation-depen-
dent.
WHAT ARE THE FACTORS THAT INFLUENCE QSM
MEASUREMENTS?
The susceptibility values measured by QSM are fundamentally
determined by the molecular composition within an imaging
voxel. They are also, however, affected by the nature of the MRI
process. In bulk biological tissues as imaged by MRI, each voxel
contains an ensemble of molecules of different kinds—all situ-
ated within a complex cellular environment. Given the finite
resolution of MRI, susceptibility determined by QSM is only a
sampled approximation of the true susceptibility distribution.
This sampling process includes not only the digital sampling of
the k-space but also the sensing of the local magnetic field based
on a certain MRI signal-generating nucleus, most often the
proton. As a result, the susceptibility measured by QSM is
influenced by the spatial variations of proton density as well as
the relaxation properties of proton spins.
Molecular and Cellular Composition
Biological cells contain a myriad of molecules and ions. Each
has its own magnetic susceptibility (40). The arrangement of
cells within a tissue further complicates its magnetic property. It
is thus nearly impossible to theoretically calculate the exact
magnetic susceptibility of a cell or a volume of tissue. Never-
theless, within an imaged organ or body, all cells have some
common features such as a lipid membrane, cytosol, and organ-
elles, whereas QSM detects only the magnetic susceptibility
variations within the tissue rather than absolute susceptibility.
In other words, it is the relative portions of these molecules,
especially those of strong susceptibility, that determine the con-
trast within a QSM image. For example, in white matter, lipids
become the dominating sources as a result of the heavy myeli-
nation of axons (which is not a feature of other cell types). In
deep brain nuclei, iron-containing molecules are the main
sources of their paramagnetism; in the kidney, the membranes
of nephrons appear to be the leading source; and in the myo-
Quantitative Susceptibility Mapping
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cardium, -helixes of myofilaments are the major sources of
anisotropy. In pathological tissues, focal depositions of minerals
such as calcium, copper, and iron have been found to be a major
cause of susceptibility changes.
Tissue Microstructure
In addition to the molecular composition of a single cell, MRI-
measured susceptibility is also highly dependent on the struc-
ture and arrangement of cells within a voxel. Thus, magnetic
susceptibility can be used as a tool to probe tissue microstruc-
ture; for example, STI exploits the anisotropic susceptibility of
certain tissues to determine the dominant orientation of the
structures within a voxel, and p-space multipole frequency
mapping aims to infer the subvoxel magnetic field distribution
(41, 42).
STI describes an anisotropic susceptibility tensor as opposed
to the scalar quantity associated with isotropic QSM (41). Mea-
suring the observed frequency offsets at multiple orientations
with respect to the main field, B0, solves the susceptibility
tensor. The susceptibility tensor is related to frequency shift in
the subject frame of reference according to the following (41):
fk 	B013H^ kH^  H^ CkkTkH
^
k2
 (5)
where  is a second-order susceptibility tensor, Hˆ is the unit-
applied magnetic field vector, and B0 is the magnitude of the
magnetic flux density of the applied field. Assuming symmetry,
there are 6 independent variables to be determined in the tensor.
Thus, a minimum of 6 independent measurements are required,
although fewer measurements are made possible through further
assumptions and by utilizing mutual information from diffusion
tensor imaging (DTI) (19, 43). Rotation of the object of interest
with respect to the main field allows these independent mea-
surements to be acquired. Estimating a susceptibility tensor is
attained through inversion of the system of linear equations
formed by Equation 5. The estimated susceptibility tensor can be
decomposed into 3 eigenvalues, representing principal suscep-
Figure 2. Atomic origin of paramagnetic and diamagnetic susceptibility. (A) Paramagnetic susceptibility originates pri-
marily from spin and orbital angular momentum induced magnetic moments (s and L, respectively) of electrons. Elec-
trons can be found in these quantized momentum levels following the Boltzmann distribution, resulting in an expected
magnetic moment eff and an paramagnetic susceptibility inversely proportional to temperature. (B) Diamagnetic suscep-
tibility originates from the precession of orbital electrons about the applied external magnetic field. The precession of
electrons is modeled as a circular current, which generates a secondly field opposing the applied magnetic field. Thus,
the resulting susceptibility is diamagnetic.
Quantitative Susceptibility Mapping
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tibilities, and the associated eigenvectors (Figure 3). An orien-
tation map can be formed for the principal susceptibility based
on the direction of the associated eigenvector. Fiber tracks can
then be reconstructed based on the STI (Figure 3) in a process
similar to DTI (21, 44).
Applications of STI include but are not limited to the char-
acterization of white matter fiber tracks both in vivo and ex
vivo, as well as mapping the renal tubule and cardiac myofiber
architecture ex vivo (21, 22, 41, 44).
STI of white matter is possible because of the presence of
ordered bundles of axons that form fibers within the central
nervous system. He and Yablonskiy pointed out that white
matter frequency varies with the angle between axons and the
applied magnetic field simply due to the elongated structure of
the axons, but assuming isotropic susceptibility (45). Li et al.
provided both theoretical and experimental data that demon-
strated that the orientation-dependent susceptibility observed in
the white matter results from the anisotropic susceptibility of
myelin lipids. Later, Wharton and Bowtell found that when
modeling axons as hollow cylinders, the anisotropic suscepti-
bility of myelin is necessary to fully explain the observed be-
havior of the GRE phase (46). If sufficient multiple-orientation
GRE data is acquired, the fiber tracks can be reconstructed with
comparable quality to DTI in the major white matter tracks (47).
Tubular structures in the nephron of the kidney exhibit
similar susceptibility anisotropy as that of white matter fibers
(21). The tubules are made up of renal epithelia that also possess
lipid bilayers composed of magnetically anisotropic lipid chains.
For the kidney, STI may provide more extensive tracking of the
tubules compared with DTI, as shown in a study on mouse
kidneys (21). Whereas DTI is limited to the inner medulla, STI
has the ability to track the tortuous tubules of the outer medulla
and some of the cortex (21).
Significant susceptibility anisotropy is also present in the
myocardium, arising from the composition and arrangement of
myofilaments. A multifilament model revealed that the arrange-
ment of diamagnetically anisotropic peptide bonds that make up
the myofibers produced the bulk susceptibility anisotropy of
cardiac tissue (22). Thus, STI enables mapping of the myofiber
architecture, with complementary results to DTI.
Unfortunately, STI has obvious limits in terms of clinical
applicability because of the multiple-orientation requirements
hindered by scanning time limits and limited rotation within
current transmit/receive coil arrays. Thus, nonrotational meth-
ods for investigating microstructure based on MRI-measured
susceptibility are of great interest. If the structures within a
voxel are heterogeneous, the magnetic field distribution within
that voxel will also be heterogeneous. In principle, the field
variation for a single myelinated axon will be minimal in the
direction parallel to the axon but vary rapidly in the perpendic-
ular direction. Unfortunately, the result of a standard GRE se-
quence is a single phase value for a given voxel that represents
Figure 3. Illustration of STI on a mouse brain. Mouse brain was perfusion-fixed with formalin and stained with a gadolinium
contrast agent. 3D Multiecho GRE data were acquired in 12 specimen directions on a small-bore animal 7T scanner. (A) The
6 independent tensor elements of a representative slice. (B) 1, 2, and 3 are the 3 eigenvalues representing the principal
susceptibilities. (C) MSA and the color-coded MSA were calculated based on the associated eigenvector orientations. Fiber
tracking was performed using Diffusion Toolkit in a process similar to DTI, and results were visualized using TrackVis. The
track image shows the tracks intersecting 10 adjacent slices.
Quantitative Susceptibility Mapping
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the summation of field offsets within that voxel. All spatial
heterogeneity within the voxel is lost during the ensemble av-
eraging. A spectral analysis technique in Fourier spectrum
space, termed p-space, was proposed to recover the subvoxel
field distribution and infer the underlying microstructure (42).
This method has been proven effective through extensive sim-
ulations, but its merit under practical imaging constraints is still
under investigation (42, 48-50).
Imaging Factors
Because QSM relies on a signal-generating nucleus of an atom
to sense the local field variations, the measured susceptibility is
inherently influenced by the properties of these atoms. For
example, are they uniformly distributed or compartmentalized?
Do they have different relaxation properties? In the white mat-
ter, the myelin sheath possesses anisotropic and diamagnetic
lipid chains, resulting in an increasingly more negative fre-
quency shift in the myelin and axonal water (ie, appearing more
diamagnetic) as the fiber angle increases from 0 to 90°. As the
field inhomogeneity increases, the signal dephases more rapidly,
which contributes to magnitude decay characterized by a vary-
ing T2* relaxation rate in GRE. The myelin water component has
a short T2* compared with the axonal and extracellular space;
thus, there is an absence of the myelin water signal at later TEs.
An appropriate echo time must therefore be used to attain the
frequency contribution from the myelin water component. Fre-
quency shifts that originate more locally can be attained by
computing the difference between a short and long TE, allowing
the myelin water frequency to be isolated in a method termed
frequency difference mapping (46, 51).
Cells also have elaborated mechanisms for maintaining the con-
centration gradients ofmany important ions andmolecules across the
cell membranes. For instance, 1H protons are more abundant in the
intracellular than extracellular space (intra/extra, 70:30), whereas
23Na has amuch higher concentration in the extracellular space com-
pared with the intracellular space (extra/intra, 142:10) (34, 52). Phos-
phates, on theother hand, aremostly stored intracellularly (extra/intra,
2:149). Thus, in standardprotonMRI, thephasevalues of the signal are
weighted more heavily by intracellular protons, whereas in 23Na MRI
the phase highly reflects the field contribution from the extracellular
space (Figure 4).
The specific algorithmic steps taken to process the phase images
and subsequently compute the susceptibility values also affect the
quality of the resultingQSMmaps. First, it is critical to generate a good
maskof theVOI, excluding regions of unreliable phase values. Second,
although different background phase removal algorithms produce
phase maps that generally look similar, there are visually appreciable
differences mainly in the low-frequency components. These differ-
ences may produce differences in the QSM maps, mostly around the
edges. Third, the reproducibility and consistency within an inversion
algorithm are generally found to be excellent (53, 54). There is still a
lack of data, however, that compare different algorithms comprehen-
sively such as truncated k-space division, LSQR and iLSQR,MEDI, and
L1 and L2 norms (5, 8-14, 20, 35, 36).
WHAT ARE THE CLINICAL APPLICATIONS OF
QSM?
Magnetic susceptibility is influenced by a wide range of physi-
ologically significant molecules. The state and concentration of
these molecules may change in diseased tissues. Therefore, QSM
Figure 4. Effect of compartmentalization on measured frequency shift. (A) Simulated subvoxel frequency distribution of
1H and 23Na for a white matter fiber bundle, perpendicular to the main magnetic field at 3T. Approximately 70% of
water protons are intracellular, whereas approximately 95% of 23Na is extracellular. (B) A single value for the voxel at
each TE was attained through a complex summation of all subvoxel points. The weighting of intra-axonal and extracellu-
lar pools significantly affects the resulting frequency values and temporal evolution.
Quantitative Susceptibility Mapping
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is being evaluated in a growing number of clinical applications.
The most readily translatable applications include, among oth-
ers, (1) the separation of diamagnetic calcium from paramag-
netic iron, (2) the quantification of iron deposition and blood
byproducts, and (3) the quantification of myelination in the
white matter.
Hemorrhage
GRE is more sensitive than computed tomography for detecting
intracerebral hemorrhage (55, 56). However, T2*-weighted hy-
pointensity in GRE suffers from blooming artifacts that are
highly dependent on imaging parameters. Conversely, QSM
based on GRE phase data has become sufficiently accurate for
measuring the strong susceptibilities of biomaterials, including
deoxyhemoglobin in the veins and blood degradation products.
QSM can accurately measure the hemorrhage volumes by re-
moving blooming artifacts inherent in traditional T2*-weighted
imaging (57).
QSM can easily differentiate diamagnetic calcification from
paramagnetic materials such as hemosiderin (58, 59), whereas
both calcification and chronic hemorrhage appear hypointense
on GRE magnitude images (Figure 5). Chen et al. demonstrated
that QSM is superior to GRE imaging in differentiating intracra-
nial calcifications from hemorrhage (59). Thus, QSM may be
used as a more accurate detection and measurement of microb-
leeds in GREMRI (60, 61). It has also been reported that QSM can
reliably measure hematoma volume (8, 9). Further, during blood
degradation in hemorrhage, susceptibility progressively in-
creases from oxyhemoglobin (diamagnetic) to deoxyhemoglo-
bin (paramagnetic), methemoglobin (strongly paramagnetic),
and hemosiderin (super paramagnetic) (58, 62). Therefore, QSM
may be used to precisely quantify and spatially depict dynam-
ically evolving susceptibility over time. This susceptibility
change reflects the evolution of blood product degradation thus
may provide useful information allowing for a more precise
management of hemorrhage patients.
Brain Development
It is well known that the neonatal brain structure and myelina-
tion change rapidly during early development, leading to dif-
ferences in brain tissue composition compared with the adult
brain. Both human and mouse brains are poorly myelinated or
unmyelinated at birth. Myelination occurs rapidly in the first
few years of life for humans and in the first few weeks for
rodents. Zhong et al. showed that phase difference between gray
and white matter was greatly reduced in human neonates com-
pared with adults (63). In the developing mouse brain from
postnatal day 4 (PND4) to PND40, it was shown that phase
contrast between gray and white matter correlated with the
optical intensity of myelin-stained histological slides (64). How-
ever, these studies were based on phase contrast rather than the
intrinsic tissue susceptibility. In the human brain, Li et al. re-
ported that white matter became more diamagnetic as the brain
developed from 1 to 83 years of age (65). In the mouse brain,
Argyridis et al. (66) evaluated the temporal evolution of mag-
netic susceptibility in the white matter of mouse brain from
PND2 to PND56. They showed that, at PND2 and PND7, white
matter appears paramagnetic compared to surrounding gray
matter (Figure 6). Its magnetic susceptibility then became in-
creasingly diamagnetic as the brain developed. Furthermore, the
increasing diamagnetism correlated well with the increasing
myelin as depicted by myelin staining intensity.
Besides the diamagnetism, another important characteristic
of white matter is that the magnetic susceptibility anisotropy
(MSA) is directly proportional to myelin concentration (67).
Argyridis et al. (66) also found that susceptibility anisotropy
Figure 5. Quantitative suscepti-
bility mapping for measuring
paramagnetic (microbleeds) and
diamagnetic (calcifications) bio-
materials on a 45-year-old female
patient. Note that calcification in
the choroid plexus (yellow arrow)
has a similar hyperintense ap-
pearance as a microbleed on the
R2*. This ambiguity is removed
on the QSM map. The scan pa-
rameters are as follows: in-plane
resolution  0.86  0.86 mm2;
matrix  256  256; flip angle
 12°; TE of first echo  3 ms;
echo spacing  3.08 ms; TR 
54 ms; and number of echoes 
8. Slice thickness  1 mm.
Quantitative Susceptibility Mapping
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increased monotonically as a function of age from PND2 to
PND56. It was further shown that MSA reached 0.02 ppm by
PND22 compared to just0.0028 ppm at PND14 and continued
to grow through PND56, reaching 0.026 ppm (Figure 6).
The sensitivity of QSM to myelination may therefore be
useful for monitoring delayed myelination or the loss of myeli-
nation during early brain development. For example, in a recent
study of a mouse model of fetal alcohol spectral disorder, QSM
revealed clear and significant abnormalities in the anterior com-
missure, corpus callosum, and hippocampal commissure that
likely resulted from reduced myelination (68). The study also
suggested that QSM may be even more sensitive than DTI for
examining changes resulting from prenatal alcohol exposure.
Aging
In white matter, the measured magnetic susceptibility has been
related to diamagnetic myelin lipids and proteins of the myelin
sheath. Li et al. observed a biphasic pattern of susceptibility
change in white matter tracts, such as the internal capsule, the
splenium of corpus callosum, and the optic radiation, with an
initial decrease followed by an increase (65). This is consistent
with known maturation and decay in the course of normal brain
development and aging (69). The temporal characteristics, espe-
cially the time to reach minimum susceptibility, vary among
different white matter fiber bundles. For instance, susceptibili-
ties of the internal capsule, the splenium of corpus callosum, and
the optic radiation reach their minimums at 45, 32, and 26 years,
respectively.
In deep gray matter, iron accumulation throughout the
lifespan has been well documented. Interest in quantifying iron
deposition in deep gray matter regions using QSM has increased
recently. Combined with x-ray fluorescence imaging, an ex vivo
QSM study has established positive correlations between iron
measurements and susceptibility values in deep gray matter
regions (70). In 2 groups of extreme age (elderly group: age 
74.4 7.6 years, n 11; young group: age 24.0 2.5 years,
n  12), Bilgic et al. demonstrated a strong significant correla-
tion between susceptibility and postmortem iron measurements
in deep gray matter regions (r  0.881). Significantly higher
susceptibility values in the elderly group versus the young group
have also been observed in regions such as the putamen, globus
pallidus, and red nucleus (16).
In a more comprehensive study of 191 consecutively aged
individuals (7-87 years), nonlinear increase of susceptibility
with aging has been observed in the globus pallidus, red nu-
Figure 6. (A) Examples of magnetic susceptibility maps of the developing mouse brain. White matter largely appears
paramagnetic relative to gray matter in PND2 and PND7, whereas contrast is weak at PND14. At PND22 and PND56,
white matter appears to be diamagnetic. (B) Magnetic susceptibility contrast of selected white matter regions relative to
neighboring gray matter as a function of age. (C) Apparent magnetic susceptibility of the fornix system as a function of
sin2, where  is the fiber angle with respect to B0. The slope of the fitted trend line increases as the brain develops,
indicating increasing anisotropy. The scan parameters are as follows: isotropic resolution  59  59  59 m3;
matrix  368  184  184; flip angle  40°; TE  20 ms; and TR  200 ms. Reproduced with permission from
Argyridis et al. (66).
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cleus, substantia nigra (SN), and dental nucleus. Relatively more
linear increases with aging were found in the putamen and
caudate nucleus throughout all ages investigated. The plateau of
susceptibility in the globus pallidus was found between the ages
of 20 to 30 years. One specific finding in the globus pallidus is
the inner and outer globus pallidus can be differentiated before
the age of 27 years that later become indistinguishable. One
possible explanation is that the medial medullary lamina grows
thinner with aging. Higher susceptibility in the posterior puta-
men than the anterior has also been observed after the age of 27
years (65). It is important to note that elevated iron in this
healthy elderly group was found to be associated with motor
function decline (71).
In a recent study focused on age-related susceptibility
change after the age of 20 years, Gong et al. reported that
regional susceptibility levels (ranking from highest to lowest)
are as follows: the globus pallidus, substantia nigra, red nucleus,
caudate nucleus and putamen, and thalamus. In the age range
investigated (25-78 years), linear age effects on susceptibility
values were confirmed in regions other than the globus pallidus,
and the rates varied, with the putamen exhibiting the highest
rate of increase—twice that observed in the substantia nigra and
caudate nucleus. Gong et al. further showed that hemisphere and
gender-related differences existed in deep gray matter regions.
Significant leftward asymmetries in iron content were observed
in the substantia nigra and caudate nucleus. Gender difference
was observed in the thalamus and red nucleus, where men have
a higher iron level than women (72). These findings in deep gray
matter regions may provide new clues for unveiling the under-
lying mechanisms of iron-related neurodegenerative diseases.
Parkinson Disease and Presurgical Planning
The development of Parkinson disease (PD) is associated with
dopaminergic cell loss and iron accumulation in the pars com-
pacta (PC) within the SN. Recent studies have shown QSM to be
a potentially useful tool in helping to diagnose and treat PD
because of its sensitivity to variation in iron levels. In vivo
studies have shown that QSM values are increased in the PC in
PD patients relative to those measured in healthy controls
(73-75) and that QSM is more sensitive than R2 and R2* mea-
surements in discriminating between patients and healthy con-
trols (74, 75). As such, QSM provides a useful, more quantitative
means of assessing abnormal iron deposition in PD.
QSM has also been found to be sensitive enough to detect
disturbed iron distribution in early idiopathic PD. In a recent
study by He et al. (76), the intergroup differences of susceptibil-
ity and R2* value in deep gray matter nuclei, including the head
of caudate nucleus, putamen, global pallidus, substantia nigra,
and red nucleus, and the correlations between regional iron
deposition and the clinical features were explored in 44 early PD
patients and 35 gender- and age-matched healthy controls.
Susceptibility values were found to be elevated within the bilat-
eral SN and red nucleus contralateral to the most affected limb
in early PD compared with healthy controls. In comparison,
increased R2* values were only seen within the SN contralateral
to the most affected limb in the PD group compared with con-
trols. Furthermore, it was found that bilateral SN magnetic
susceptibility positively correlated with disease duration and
the Unified Parkinson Disease Rating Scale III (UPDRS III)
scores in early PD (Figure 7). This finding further supports the
potential value of QSM as a noninvasive quantitative bio-
marker of early PD.
Deep brain stimulation (DBS) is an effective treatment for
the symptoms of PD (77, 78) and involves implanting stimulat-
ing electrodes in the brain. Precise placement of these electrodes
is essential for delivering the desired effects and minimizing side
effects (79-82), and presurgical imaging is essential for deter-
mining patient suitability and guiding surgery (83-85). The
dorsolateral portion of the subthalamic nucleus has been iden-
tified as the optimal stimulation site in the treatment of PD (86);
the medial globus pallidus may also be targeted (87). QSM has
been shown to be superior to conventional MRI protocols in
depicting both the subthalamic nucleus (88) and medial globus
pallidus (87), meaning that it may improve presurgical planning
for treating PD with DBS.
Multiple Sclerosis
MRI is a well-established tool in diagnosing and investigating
multiple sclerosis (MS); however, common MRI measurements
such as lesion number or total lesion volume have not been
shown to predict disease progression (89). QSM has become
increasingly prominent in the search for a quantitative bio-
marker to measure tissue changes that occur in MS, with a focus
on quantifying iron levels in the deep gray matter, and identi-
fying regions of demyelination and iron accumulation during
the formation of MS lesions (Figure 8) (17, 90-99).
Langkammer et al. (18) showed that susceptibility values in
the deep gray matter measured using QSM correlated with in-
creased iron levels measured using inductively coupled plasma
mass spectrometry, suggesting that in this region QSM values
may be assumed to mainly reflect local iron levels. Several
studies have shown that QSM values are significantly increased
in the deep gray matter in patients with clinically definite MS or
a clinically isolated syndrome that suggests MS relative to
healthy controls (90, 91, 95); in addition, these increases have
been shown to correlate with expanded disability status scale
measures of disability (95). It is thought that iron accumula-
tion in the central nervous system may promote damage
through oxidative stress, blocking repair mechanisms, acti-
vating microglia and macrophages, and/or facilitating mito-
chondrial changes that lead to cellular degradation (100).
Combining QSM and R2* data has been shown to improve
automated segmentation of deep gray matter structures in
high (3T and higher) field-strength MRI compared with seg-
mentation based on T1-weighted images.
Assessing white matter changes in MS using QSM is more
challenging because of the combination of demyelination,
which causes a net increase in susceptibility as a result of the
loss of diamagnetic myelin, and the accumulation of paramag-
netic iron in ferritin and presence of iron-bearing inclusions
such as microglia and macrophages, which also causes an in-
crease in susceptibility. Furthermore, the loss of iron-bearing
oligodendrocytes during demyelination may offset some my-
elin loss by decreasing net susceptibility (99). Although
attempts have been made to separately quantify iron and
myelin levels by combining QSM data with quantitative R2*
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data (101), recent studies of white matter lesions in MS have
inferred the definite presence of iron from QSM values greater
than 0 ppm relative to the ventricular cerebrospinal fluid
(CSF), because complete demyelination cannot raise the sus-
ceptibility beyond this value (97).
QSM is increasingly used in the study of MS lesions,
where it has been shown to more accurately depict the het-
erogeneous distribution of magnetic susceptibility in such
lesions more accurately than phase imaging (96). Li et al.
compared the appearance of MS lesions identified using MP-
Figure 7. QSM of early-stage PD illustrates the regions of deep brain nuclei (A, B): the head of caudate nucleus (CN);
putamen (PUT); globus pallidus (GP); substantia nigra (SN); and red nucleus (RN). (C) Scatter plots and regression lines
show the significant relationship between susceptibility values in bilateral SN and clinical measures in early-stage PD.
Correlations are partialed for age. The susceptibility value of ipsilateral SN is positively correlated with disease duration
(top left: r  0.391, P  .0094) and UPDRS III score (bottom left: r  0.386, P  .0105) in PD. The susceptibility value
in SN contralateral to the most affected side in PD patients is positively correlated with disease duration (top right: r 
0.347, P  .0226) and UPDRS III score (bottom right: r  0.368, P  .0152). Reproduced with permission from He et
al. (76).
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FLAIR and T1 MPRAGE magnitude images in R2* and QSM
images and found that lesions may be either isointense or
hyperintense in QSM and are mostly diamagnetic relative to
CSF, with QSM isointense lesions suggesting slightly higher
myelin levels (99). A small number of lesions may have a
positive susceptibility relative to CSF, suggesting increased
iron levels and possibly complete demyelination (99). Wis-
nieff et al. (97) compared QSM of white matter lesions to
histological iron staining and suggested that in completely
demyelinated lesions, iron levels may be directly quantified
using QSM. Chen et al. (94) compared the temporal evolution
of QSM values in white matter lesions and found that sus-
ceptibility increased from similar values to normal-appearing
white matter (NAWM) in acute enhancing lesions and re-
tained significantly higher susceptibilities in early to inter-
mediate nonenhancing lesions, but returned to similar values
to normal-appearing white matter in chronic nonenhancing
lesions.
Alzheimer Disease
The basal ganglia are reported as the earliest and most intense
accumulators of -amyloid (A) in individuals genetically pre-
disposed to develop Alzheimer disease (AD) in the future (102).
Iron overload in the basal ganglia is also a well-known feature
of AD (103). Therefore, accurately quantifying iron levels in
vivo using QSM could possibly provide useful biomarkers for
diagnosing AD.
In a relatively small cohort (8 controls and 8 AD patients),
Acosta-Cabronero et al. investigated susceptibility values using
both region-based and whole-brain analysis approaches. Abnor-
malities of susceptibility values were found in several gray and
whitematter regions. Themost interestingfindingwas in theputamen,
where a higher susceptibility value was found in AD patients com-
pared with controls (104). Promising results were reported in another
study of 6 AD patients and 10 controls. The susceptibility of gray
matter was found to be higher in A PET-positive AD patients com-
pared with A-negative healthy controls (105).
Inconsistent results have also been reported by recent stud-
ies of patients at early stages of the disease. A study of 18 mild
cognitive impairment (MCI) patients and 22 healthy controls
showed no significant difference in the basal ganglia and cor-
tical gray matter between groups, suggesting that magnetic
susceptibility may not be sufficient to serve as a biomarker for
diagnosis at early stages of disease initiation (106). Another
study of MCI patients and healthy elderly individuals investi-
gated the relationship between magnetic susceptibility and A
measured by Pittsburgh compound B PET. Although no corre-
lation was found for healthy controls, strong positive correla-
tions were observed in the caudate nucleus and frontal, tempo-
ral, parietal, and occipital lobes for MCI patients. These findings
suggested that cerebral iron accumulation might reflect A-
associated brain dysfunction (107). One possible explanation for
the discrepancy between these 2 studies could be the high
heterogeneity of the MCI group.
To date, QSM studies of AD are scarce, yet the results are
encouraging. Further studies dedicated to relating susceptibility
with other established biomarkers for diagnosing AD and espe-
cially MCI are needed to provide additional information for
establishing the role of QSM for diagnosing and managing AD
patients.
Oxygenation
Oxygenation imaging could provide biomarkers for studying
cerebral physiology and improving understanding of disorders
in which the oxygen supply is disturbed, such as stroke, tumor,
and Alzheimer disease. In vessel segments that can be approx-
imated as an infinite cylinder, the susceptibility difference be-
tween vein and tissue follows Xvein–tissueXdo Hct OEF,
where Xdo  0.18 ppm is the susceptibility difference per unit
hematocrit (Hct) between fully deoxygenated blood and fully ox-
ygenated blood. Oxygen extraction fraction (OEF) can be calcu-
lated by measuring the susceptibility difference Xvein–tissue. Ac-
cording to the Fick principle, the cerebral metabolic rate for oxygen
(CMRO2) can be expressed as CMRO2OEFCBFCa, where the
carrying capacity of oxygen molecules per volume of blood (Ca) is
a typical constant. By measuring cerebral blood flow (CBF) using
Figure 8. Examples of QSM in the investigation
of MS. (A) QSM values can be used as a marker
of iron deposition in the deep gray matter, which
is characteristic of MS. The susceptibility map
shows good delineation of the deep gray matter
structures in closer agreement with the magnitude
image than the nonlocal phase contrast. (B) Some
white matter lesions identified on GRE magnitude
images appear in susceptibility maps as a result
of either reduced myelin content, increased iron
content, or a combination of these factors. Here,
the QSM data depicts the lesion with a clear hy-
perintense core; however, the phase contrast is
distorted, with a poorly defined lesion edge. The
scan parameters are as follows: 7T; 0.5-mm3 iso-
tropic resolution; TE  20 ms; TR  150 ms;
FOV  196  164  85 mm3; EPI factor  3;
and SENSE factor  2. Images courtesy of the Sir
Peter Mansfield Imaging Centre, University of Not-
tingham, United Kingdom.
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other MRI protocols such as arterial spin labeling, local CMRO2
could be also estimated.
Several QSM-based studies sought to measure OEF and
CMRO2 and to compare the measurements to previously pub-
lished results based on other MRI methods and PET imaging. In
12 healthy volunteers, Fan et al. reported a mean venous oxygen
saturation of 59.7  2.4% and a mean CMRO2 of 151  15
mol/100 g/min using the QSM-based method (108). Similarly
assuming constant arterial oxygenation saturation level and
total hemoglobin concentration, Zhang et al. generated quanti-
tative maps of CMRO2 and OEF before and after caffeine vaso-
constriction in 13 healthy volunteers. The reported CMRO2 of
153 26.4 mol/100 g/min agreed well with previous MRI and
PET literature (109). In 10 healthy individuals, Fan et al. also
measured a strong reduction of local venous OEF during hyper-
capnia relative to baseline. For instance, OEF decreased by 40%
in the straight sinus and in the internal cerebral veins that drain
the deep gray matter (110). In MS patients, Fan et al. also
observed a 3.4% absolute reduction of mean cortical OEF in MS
relative to healthy controls. A weak correlation between OEF
and cortical thickness was observed. Interestingly, OEF strongly
correlated with cognitive performance, particularly informa-
tion-processing speed. A trend of progressive decrease in OEF
with MS disease type was also reported (111).
More recent studies of patient populations have focused on
comparing QSM-derived OEF measurements directly with PET-
based OEF measurements. In 27 patients with steno-occlusive
cerebrovascular diseases, Uwano et al. reported a strong corre-
lation between the OEF ratio on the QSM-OEF maps and that on
the PET-OEF maps (r  0.89, P 	 .001) (112). In another study
of 26 patients with chronic cerebral ischemia, Kudo et al. re-
ported a moderate correlation between QSM-OEF and PET-OEF
measured by the gold standard 15O PET (r  0.60, P  .001)
(113). These works demonstrated that QSM-based noninvasive
measurements of OEF and CMRO2 can provide information
regarding cerebral physiological changes and raise the prospect
of QSM as an alternative to 15O2 PET for accessing patients with
disruption in cerebral metabolism.
Practical Matters of Clinical Translation
It is relatively straightforward to collect QSM data on a typical
clinical MRI scanner because QSM uses the widely available 2D
or 3D GRE sequence. In fact, many clinical protocols are already
collecting 2D or 3D GRE data to obtain T2* or susceptibility
weighting. A typical protocol for neural applications at 3T
would be able to achieve a whole-brain coverage at an approx-
imately 0.8-mm in-plane resolution and with a slice thickness
approximately 2 mm in approximately 6 minutes of scan time.
Faster scanning can be achieved with echo-planar imaging
(EPI), spiral trajectories or the recently proposed Wave-CAIPI
technique (114-117). Although 2D EPI is generally available, the
other faster sequences are not yet widely available on clinical
scanners. As susceptibility contrast and signal-to-noise ratio
improves with field strength, it is generally beneficial to use a
higher field strength when possible. Higher field strengths
shorten T2*, allowing for shorter TEs and TRs and thus faster
scans. For a given retention time, it is also beneficial to collect as
many echoes as possible for improved efficiency and signal-to-
noise ratio through multiecho averaging.
Currently, the main hurdle for broadly translating QSM into
the clinics is that MRI vendors have yet to implement the
necessary algorithms on their commercial scanners. First, most
scanners do not store the phase images by default. Some sus-
ceptibility-weighted imaging protocols output phase images
that are high-pass filtered, which removes much of the useful
phase information. Some scanners produce phase images that
contain discontinuities of singularity points or “open fringe
lines” that are usually caused by an incorrect combination of
images produced by multichannel coils. Given that the manu-
facturers are still working out their preferred ways to generate
phase images, it still makes sense currently to store the unpro-
cessed complex images of each coil and process them offline
with in-house written or publically available software. If this is
impractical for reasons such as increased storage space, it should
be ensured at a minimum that the phase images generated by the
scanner are not filtered improperly. Second, MRI vendors have
not implemented QSM algorithms to solve the phase-to-suscep-
tibility inverse problem. However, there is shareware (eg, STI
Suite from Duke University) available for research purposes (13).
Nevertheless, to broadly evaluate and apply QSM in clinical
radiology would require the scanners to generate QSM maps
automatically.
Although QSM of the brain has been most widely evaluated
and is most readily translatable to the clinics, QSM of the body
remains to be fully developed and optimized. The main chal-
lenge of body QSM is dealing with motion and water fat sepa-
ration. However, early reports have shown promises in the
kidney (23, 38), liver (24), heart (22), and cartilage (118, 119).
CONCLUSIONS
QSM has revealed extensive variations of magnetic susceptibil-
ity among biological tissues and between healthy and diseased
tissues. Studies have shown that these variations are most often
caused by their unique composition of molecules with distinc-
tive magnetic properties and their microscopic tissue organiza-
tion. Normal physiologic and abnormal disease processes can
cause changes in the molecular and cellular level, resulting in
measurable changes in magnetic susceptibility. QSM is thus
becoming a valuable MRI tool for quantitatively assessing tissue
property.
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